SEQUELLA INC.

Filings

Date Type Incremental Filing
10/10/17 New $630,589 SEC
9/22/16 New $940,942 SEC
9/22/16 New $1,724,250 SEC
10/10/14 New $3,100,000 SEC
10/1/13 New $555,000 SEC
9/4/12 New $100,000 SEC
11/4/11 New $50,000 SEC
8/10/11 New $550,000 SEC
6/2/11 New $1,000,000 SEC
2/22/10 New $2,000,000 SEC
8/20/09 New Unknown SEC
7/9/09 New Unknown SEC
8/29/08 Paper Filing Unknown N/A
8/29/08 Paper Filing Unknown N/A
3/12/08 Paper Filing Unknown N/A
5/31/07 Paper Filing Unknown N/A
5/11/07 Paper Filing Unknown N/A
5/30/06 Paper Filing Unknown N/A
5/12/06 Paper Filing Unknown N/A
4/21/06 Paper Filing Unknown N/A
1/6/06 Paper Filing Unknown N/A
5/23/05 Paper Filing Unknown N/A

Directors and Executives (Current and Past)

Name Role
Leo Einck Director, Executive
John Friedman Director
Gary Horwith Executive
William Hoskins Director
Alan Klein Executive
Kenneth Lynn Director
Paige Macdonald Director
Paige Mac Donald Director
David Mcneeley Executive
Ronald I. Meltzer Director
Lawrence Miller Executive
Carol A. Nacy Director, Executive
Mark Rampy Executive
Bradley Rotter Director
Martin M Zug Executive

Industry: Pharmaceuticals (See others in industry)

Address:
9610 Medical Center Dr Suite 200
Rockville, MD, 20850
Phone: 301-762-7776